About Index Trending news
Analyze
Pricing
Cell Medica

Cell Medica

Work at Cell Medica? Add yourself to this profile

Cell Medica

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$74,100,000
Venture capital (Series B)
$78,382,191
Employees

Unknown size

Locations
HQ
$74,100,000 Venture capital (Series C)
PE Hub

Cell Medica pulls in about $74.1 mln Series C

Funding
FinSMEs

Cell Medica Closes £60M Series C Funding

Funding Health Science